cGMP-dependent protein kinases as potential targets for colon cancer prevention and treatment.
about
Plants vs. cancer: a review on natural phytochemicals in preventing and treating cancers and their druggabilityPlecanatide-mediated activation of guanylate cyclase-C suppresses inflammation-induced colorectal carcinogenesis in Apc+/Min-FCCC miceThe Role of Nitric Oxide Synthase Uncoupling in Tumor Progression.Phosphodiesterases in non-neoplastic appearing colonic mucosa from patients with colorectal neoplasia.The cyclic GMP/protein kinase G pathway as a therapeutic target in head and neck squamous cell carcinomaNovel Therapeutics: NSAIDs, Derivatives, and Phosphodiesterases.Soluble guanylate cyclase stimulators increase sensitivity to cisplatin in head and neck squamous cell carcinoma cells.cGMP Signaling Increases Antioxidant Gene Expression by Activating Forkhead Box O3A in the Colon Epithelium.Type 2 cGMP-dependent protein kinase regulates proliferation and differentiation in the colonic mucosa.Induction of apoptosis by type Iβ protein kinase G in the human breast cancer cell lines MCF-7 and MDA-MB-468.Cyclic GMP induced apoptosis via protein kinase G in oestrogen receptor-positive and -negative breast cancer cell lines.Cyclic 3',5'-guanosine monophosphate-dependent protein kinase inhibits colon cancer cell adaptation to hypoxia.Edible ginger-derived nanoparticles: A novel therapeutic approach for the prevention and treatment of inflammatory bowel disease and colitis-associated cancerThe constitutively active PKG II mutant effectively inhibits gastric cancer development via a blockade of EGF/EGFR-associated signalling cascades.Sildenafil Suppresses Inflammation-Driven Colorectal Cancer in Mice.Expression of cGMP-dependent protein kinase, PKGIα, PKGIβ, and PKGII in malignant and benign breast tumors.
P2860
Q28385642-41DC5B1E-7693-4D9D-8F97-94BE4E77C90CQ34551599-926C442A-1651-4DA7-A513-1AF01FD4CA50Q35751821-814463C9-506E-4F84-9CC6-A21F01F3FBD7Q36215141-ED428FD2-7849-4098-91CD-02BACD41A00FQ36458158-6C6C008E-9391-4C86-92FB-21EABC28F558Q36637814-7594F397-B8A8-49F2-B825-32C6BE8789CEQ38724210-FA38BA8C-0BF5-41C0-B6E0-D0F3789111FAQ38725204-4D27C31E-2ECF-4638-9A20-4ABB043EA86CQ39353975-A29C4B41-8129-48AE-8171-BA3C3484DE49Q39440899-9C8CCC42-451E-4FCB-96A1-EFD6FD7BB87EQ39503219-D540B4C7-4147-4327-9B08-5D64D59A37D7Q39544460-DDA226E9-9E6D-4726-A13C-7CFEC80A1749Q42176588-2EDA0E88-0E7E-4F64-9178-B78ECD179EBDQ49740505-58A9F91C-4CF9-44DE-9589-AA1091DEEE2BQ53187152-96890CE5-8EFB-4C46-A4CD-7588D156B707Q54301069-DF5B790D-15BD-4317-89F0-CE97F9F5AA0A
P2860
cGMP-dependent protein kinases as potential targets for colon cancer prevention and treatment.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
cGMP-dependent protein kinases ...... ncer prevention and treatment.
@en
cGMP-dependent protein kinases ...... ncer prevention and treatment.
@nl
type
label
cGMP-dependent protein kinases ...... ncer prevention and treatment.
@en
cGMP-dependent protein kinases ...... ncer prevention and treatment.
@nl
prefLabel
cGMP-dependent protein kinases ...... ncer prevention and treatment.
@en
cGMP-dependent protein kinases ...... ncer prevention and treatment.
@nl
P2093
P2860
P356
P1476
cGMP-dependent protein kinases ...... ncer prevention and treatment.
@en
P2093
Darren D Browning
In-Kiu Kwon
P2860
P356
10.4155/FMC.09.142
P577
2010-01-01T00:00:00Z